Open Access

Discussion - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Presentation

About the speakers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Doctor Dominick Joseph Angiolillo

University of Florida College of Medicine, Jacksonville (United States of America)
23 presentations
0 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
28 presentations
1 follower

4 more presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: the clinical reality.

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Extending the duration of dual antiplatelet therapy - Who could benefit?

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Thumbnail

Summary and Close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor P. Steg, Doctor D. Angiolillo, Professor S. James, Professor R. Mehran, Professor P. Steg...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk